Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

HLN vs DBVT vs KVUE vs ALKS vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HLN
Haleon plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • GB
Market Cap$40.57B
5Y Perf.+13.3%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1690.08T
5Y Perf.+1.2%
KVUE
Kenvue Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$33.77B
5Y Perf.-29.9%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.83B
5Y Perf.+20.9%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.62B
5Y Perf.-63.4%

HLN vs DBVT vs KVUE vs ALKS vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HLN logoHLN
DBVT logoDBVT
KVUE logoKVUE
ALKS logoALKS
PRGO logoPRGO
IndustryDrug Manufacturers - Specialty & GenericBiotechnologyHousehold & Personal ProductsBiotechnologyDrug Manufacturers - Specialty & Generic
Market Cap$40.57B$1690.08T$33.77B$5.83B$1.62B
Revenue (TTM)$22.01B$0.00$15.29B$1.56B$4.18B
Net Income (TTM)$3.18B$-168M$1.62B$153M$-1.82B
Gross Margin63.9%58.4%65.4%34.2%
Operating Margin21.4%19.0%12.3%-4.1%
Forward P/E21.6x14.9x24.5x5.5x
Total Debt$8.59B$22M$8.52B$70M$3.97B
Cash & Equiv.$1.32B$194M$1.06B$1.12B$532M

HLN vs DBVT vs KVUE vs ALKS vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HLN
DBVT
KVUE
ALKS
PRGO
StockMay 23May 26Return
Haleon plc (HLN)100113.3+13.3%
DBV Technologies S.… (DBVT)100101.2+1.2%
Kenvue Inc. (KVUE)10070.1-29.9%
Alkermes plc (ALKS)100120.9+20.9%
Perrigo Company plc (PRGO)10036.6-63.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: HLN vs DBVT vs KVUE vs ALKS vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HLN leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. DBVT and KVUE also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
HLN
Haleon plc
The Long-Run Compounder

HLN carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 29.0% 10Y total return vs ALKS's -12.0%
  • 14.5% margin vs PRGO's -43.5%
  • Beta 0.03 vs DBVT's 1.26
  • 10.0% ROA vs DBVT's -89.0%
Best for: long-term compounding
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +100.5% vs PRGO's -52.0%
Best for: momentum
KVUE
Kenvue Inc.
The Growth Play

KVUE is the clearest fit if your priority is growth exposure.

  • Rev growth -2.1%, EPS growth 40.7%, 3Y rev CAGR 0.4%
  • -2.1% revenue growth vs DBVT's -100.0%
Best for: growth exposure
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.00, Low D/E 3.8%, current ratio 3.55x
Best for: sleep-well-at-night
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 10 yrs, beta 1.21, yield 9.8%
  • Beta 1.21, yield 9.8%, current ratio 2.76x
  • Lower P/E (5.5x vs 24.5x)
  • 9.8% yield, 10-year raise streak, vs HLN's 2.0%, (2 stocks pay no dividend)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthKVUE logoKVUE-2.1% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.5x vs 24.5x)
Quality / MarginsHLN logoHLN14.5% margin vs PRGO's -43.5%
Stability / SafetyHLN logoHLNBeta 0.03 vs DBVT's 1.26
DividendsPRGO logoPRGO9.8% yield, 10-year raise streak, vs HLN's 2.0%, (2 stocks pay no dividend)
Momentum (1Y)DBVT logoDBVT+100.5% vs PRGO's -52.0%
Efficiency (ROA)HLN logoHLN10.0% ROA vs DBVT's -89.0%

HLN vs DBVT vs KVUE vs ALKS vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HLNHaleon plc
FY 2022
Respiratory Health
100.0%$1.6B
DBVTDBV Technologies S.A.

Segment breakdown not available.

KVUEKenvue Inc.
FY 2025
Self Care
42.2%$6.4B
Essential Health
30.6%$4.6B
Skin Health and Beauty
27.2%$4.1B
ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

HLN vs DBVT vs KVUE vs ALKS vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGKVUE

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 3 of 6 comparable metrics.

HLN and DBVT operate at a comparable scale, with $22.0B and $0 in trailing revenue. HLN is the more profitable business, keeping 14.5% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHLN logoHLNHaleon plcDBVT logoDBVTDBV Technologies …KVUE logoKVUEKenvue Inc.ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$22.0B$0$15.3B$1.6B$4.2B
EBITDAEarnings before interest/tax$5.3B-$112M$3.3B$212M$58M
Net IncomeAfter-tax profit$3.2B-$168M$1.6B$153M-$1.8B
Free Cash FlowCash after capex$3.1B-$151M$1.8B$392M$108M
Gross MarginGross profit ÷ Revenue+63.9%+58.4%+65.4%+34.2%
Operating MarginEBIT ÷ Revenue+21.4%+19.0%+12.3%-4.1%
Net MarginNet income ÷ Revenue+14.5%+10.6%+9.8%-43.5%
FCF MarginFCF ÷ Revenue+14.2%+11.9%+25.1%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year-0.4%+4.5%+28.2%-7.2%
EPS Growth (YoY)Latest quarter vs prior year+18.8%+91.5%+47.1%-4.1%-56.4%
ALKS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 6 of 6 comparable metrics.

At 18.7x trailing earnings, HLN trades at a 24% valuation discount to ALKS's 24.5x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than ALKS's 17.0x.

MetricHLN logoHLNHaleon plcDBVT logoDBVTDBV Technologies …KVUE logoKVUEKenvue Inc.ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Market CapShares × price$40.6B$1690.08T$33.8B$5.8B$1.6B
Enterprise ValueMkt cap + debt − cash$50.4B$1690.08T$41.2B$4.8B$5.1B
Trailing P/EPrice ÷ TTM EPS18.65x-0.75x23.14x24.47x-1.14x
Forward P/EPrice ÷ next-FY EPS est.21.59x14.94x5.53x
PEG RatioP/E ÷ EPS growth rate2.21x
EV / EBITDAEnterprise value multiple13.41x12.64x17.01x7.43x
Price / SalesMarket cap ÷ Revenue2.77x2.23x3.95x0.38x
Price / BookPrice ÷ Book value/share1.84x0.65x3.14x3.25x0.55x
Price / FCFMarket cap ÷ FCF15.17x19.61x12.14x11.17x
PRGO leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

HLN delivers a 19.9% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs PRGO's 4/9, reflecting strong financial health.

MetricHLN logoHLNHaleon plcDBVT logoDBVTDBV Technologies …KVUE logoKVUEKenvue Inc.ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity+19.9%-130.2%+15.2%+8.8%-50.7%
ROA (TTM)Return on assets+10.0%-89.0%+6.0%+5.4%-19.8%
ROICReturn on invested capital+7.6%+11.4%+18.9%+3.7%
ROCEReturn on capital employed+8.6%-145.7%+13.2%+14.2%+4.3%
Piotroski ScoreFundamental quality 0–984674
Debt / EquityFinancial leverage0.52x0.13x0.79x0.04x1.35x
Net DebtTotal debt minus cash$7.3B-$172M$7.5B-$1.0B$3.4B
Cash & Equiv.Liquid assets$1.3B$194M$1.1B$1.1B$532M
Total DebtShort + long-term debt$8.6B$22M$8.5B$70M$4.0B
Interest CoverageEBIT ÷ Interest expense7.80x-189.82x4.68x32.30x-7.20x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,165 today (with dividends reinvested), compared to $3,172 for DBVT. Over the past 12 months, DBVT leads with a +100.5% total return vs PRGO's -52.0%. The 3-year compound annual growth rate (CAGR) favors DBVT at 5.7% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricHLN logoHLNHaleon plcDBVT logoDBVTDBV Technologies …KVUE logoKVUEKenvue Inc.ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date-7.6%+3.6%+2.8%+23.8%-13.6%
1-Year ReturnPast 12 months-12.0%+100.5%-23.5%+15.2%-52.0%
3-Year ReturnCumulative with dividends+8.2%+18.1%-25.2%+13.2%-58.1%
5-Year ReturnCumulative with dividends+29.0%-68.3%-26.3%+61.7%-60.3%
10-Year ReturnCumulative with dividends+29.0%-87.1%-26.3%-12.0%-77.7%
CAGR (3Y)Annualised 3-year return+2.7%+5.7%-9.2%+4.2%-25.2%
DBVT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HLN and ALKS each lead in 1 of 2 comparable metrics.

HLN is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 95.6% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHLN logoHLNHaleon plcDBVT logoDBVTDBV Technologies …KVUE logoKVUEKenvue Inc.ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5000.03x1.26x0.24x1.00x1.21x
52-Week HighHighest price in past year$11.42$26.18$25.17$36.60$28.44
52-Week LowLowest price in past year$8.71$7.53$14.02$25.17$9.23
% of 52W HighCurrent price vs 52-week peak+79.8%+75.3%+69.9%+95.6%+41.2%
RSI (14)Momentum oscillator 0–10039.647.455.960.553.1
Avg Volume (50D)Average daily shares traded8.2M252K19.2M2.2M3.3M
Evenly matched — HLN and ALKS each lead in 1 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: HLN as "Buy", DBVT as "Buy", KVUE as "Hold", ALKS as "Buy", PRGO as "Hold". Consensus price targets imply 209.1% upside for PRGO (target: $36) vs 3.8% for KVUE (target: $18). For income investors, PRGO offers the higher dividend yield at 9.82% vs HLN's 1.98%.

MetricHLN logoHLNHaleon plcDBVT logoDBVTDBV Technologies …KVUE logoKVUEKenvue Inc.ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuyHold
Price TargetConsensus 12-month target$10.20$46.33$18.25$46.00$36.20
# AnalystsCovering analysts415142836
Dividend YieldAnnual dividend ÷ price+2.0%+4.7%+9.8%
Dividend StreakConsecutive years of raises201010
Dividend / ShareAnnual DPS$0.13$0.82$1.15
Buyback YieldShare repurchases ÷ mkt cap+2.1%0.0%+0.6%+0.5%0.0%
PRGO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...

HLN vs DBVT vs KVUE vs ALKS vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is HLN or DBVT or KVUE or ALKS or PRGO a better buy right now?

For growth investors, Kenvue Inc.

(KVUE) is the stronger pick with -2. 1% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Haleon plc (HLN) offers the better valuation at 18. 7x trailing P/E (21. 6x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HLN or DBVT or KVUE or ALKS or PRGO?

On trailing P/E, Haleon plc (HLN) is the cheapest at 18.

7x versus Alkermes plc at 24. 5x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — HLN or DBVT or KVUE or ALKS or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +61.

7%, compared to -68. 3% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: HLN returned +29. 0% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HLN or DBVT or KVUE or ALKS or PRGO?

By beta (market sensitivity over 5 years), Haleon plc (HLN) is the lower-risk stock at 0.

03β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 4292% more volatile than HLN relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — HLN or DBVT or KVUE or ALKS or PRGO?

By revenue growth (latest reported year), Kenvue Inc.

(KVUE) is pulling ahead at -2. 1% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Kenvue Inc. grew EPS 40. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HLN or DBVT or KVUE or ALKS or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLN leads at 22. 4% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HLN or DBVT or KVUE or ALKS or PRGO more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

5x forward P/E versus 21. 6x for Haleon plc — 16. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 209. 1% to $36. 20.

08

Which pays a better dividend — HLN or DBVT or KVUE or ALKS or PRGO?

In this comparison, PRGO (9.

8% yield), KVUE (4. 7% yield), HLN (2. 0% yield) pay a dividend. DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is HLN or DBVT or KVUE or ALKS or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Haleon plc (HLN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

03), 2. 0% yield). Both have compounded well over 10 years (HLN: +29. 0%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HLN and DBVT and KVUE and ALKS and PRGO?

These companies operate in different sectors (HLN (Healthcare) and DBVT (Healthcare) and KVUE (Consumer Defensive) and ALKS (Healthcare) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLN is a mid-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; KVUE is a mid-cap income-oriented stock; ALKS is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. HLN, KVUE, PRGO pay a dividend while DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

HLN

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.7%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

KVUE

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 6%
  • Dividend Yield > 1.8%
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.